Amarin Corp (AMRN)

• Market cap: $215M
• 1 day: 4.16%
• 5 days: 3.86%
• 1 month: 20.09%
• 3 months: -7.48%
• 6 months: -10.63%
• Year to date: 2.77%
• 1 year: -41.59%
• 5 years: -92.93%
• 10 years: -71.98%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Employees: 275

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

360% more call options, than puts

Call options by funds: $276K | Put options by funds: $60K

35% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 20

2% more funds holding

Funds holding: 158 [Q3] → 161 (+3) [Q4]

1.3% more ownership

Funds ownership: 15.92% [Q3] → 17.23% (+1.3%) [Q4]

16% less capital invested

Capital invested by funds: $41.1M [Q3] → $34.4M (-$6.65M) [Q4]

39% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 46

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $7 35% downside
• Avg. target: $7 35% downside
• High target: $7 35% downside

1 analyst rating

• positive: 0 0%
• neutral: 0 0%
• negative: 1 100%

Goldman Sachs Paul Choi 67% 1-year accuracy 10 / 15 met price target

35% downside $7

Sell Maintained

17 Apr 2025